Skip to main content

Table 1 Demographic and clinical data for study participants ( N = 27)

From: Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle

Demographics

 

Age

34.96 ± 4.17 (18-53)

BMI

23.47 ± 1.86 (16.8-36)

Ethnicity

 

Asian

9 (33.3%)

Caucasian

15 (55.6%)

Other

3 (11.1%)

Substance use

 

Current smoking

2 (7.4%)

Current alcohol use

20 (74.1%)

Sexual history

 

Marital status

 

Partnered

9 (33.3%)

Single

18 (66.7%)

Sexual partners in past year

1.04 ± 0.28 (0-3)

Sexual partners in past 2 months

0.78 ± 0.23 (0-2)

Vaginal intercourse during study period

17 (63.0%)

Condom use during study period

8 (29.6%)

Previous pregnancy

10 (37.0%)

Surgical sterilization

4 (14.8%)

Menstrual cycle

 

Cycle duration (days)

28.05 ± 0.68 (26-31)

Tampon use during study period

12 (44.4%)

BV and STI history

 

Diagnosed with BV, yeast, or STI in lifetime

22 (81.5%)

Diagnosed with BV in lifetime

2 (7.4%)

BV episode in past year

1 (3.7%)

Antimicrobial use in past 2 months a

 

Oral

1 (3.7%)

Topical

2 (7.4%)

  1. aNo intravaginal antibiotics.
  2. BMI, body mass index; BV, bacterial vaginosis;
  3. STI, sexually transmitted infection.
  4. Continuous variables are reported as means ± 95% CI (range).
  5. Categoric variables are reported as N (%).